Dr. John Carl Vogini, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 190 Greene Plz, Waynesburg, PA 15370 Phone: 724-627-5505 |
Richard H Goellner, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 226 Elm Drive, Suite 101, Waynesburg, PA 15370 Phone: 304-598-3301 Fax: 304-599-7346 |
Alan Eye Centers Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1159 Morris St, Waynesburg, PA 15370 Phone: 724-852-1212 Fax: 724-627-5659 |
Dr. Jeffrey Lance Weaver, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1150 7th St Ste 3, Waynesburg, PA 15370 Phone: 724-852-2200 |
News Archive
The Wall Street Journal reports that proposals for cuts in health spending by President Barack Obama's deficit-reduction commission are drawing opposition from health companies, doctors and some consumer groups. "How to tackle health costs has become a sticking point for the 18-member committee, which last week concluded three days of meetings without a firm agreement among members.
Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).
Hospitalar—Welch Allyn, a leading global manufacturer of frontline medical products and solutions, is reconfirming its commitment to caregivers in Latin America with innovative solutions to healthcare issues that are unique to the region. In March 2009 the company acquired MD International (MDI), now Welch Allyn Latin America, and has since gained significant market share in South and Central America, Mexico and the Caribbean thanks to strong relationships with large distribution and manufacturer partners.
Teva Pharmaceutical Industries Ltd. today announced that data from four late-stage studies examining QNASL (beclomethasone dipropionate [BDP]) HFA, a nasal aerosol corticosteroid in development for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) symptoms, will be presented at the 2011 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI) in Boston, Mass., November 3-8, 2011.
› Verified 8 days ago